Page 8 - Specialty Chemical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Chemours Company Agrees to Sell Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific Inc for $137 Million

The Chemours Company Agrees to Sell Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific Inc for $137 Million
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesKurt bonnerScott mrazDenise dignamThom suetaRob reistetterMark newmanSecurities exchangeCorporate communicationsChemours chemical solutionsPuretech scientific incChemours companyExchange commissionLife sciencesSpecialized solutionsGrace matthews inc

Chemours (CC) to Sell Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific for $137M

Chemours (CC) to Sell Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific for $137M
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Denise dignamRob reistetterScott mrazMark newmanPuretech scientific incGrace matthews incChemours companySpecialized solutionsChemours chemical solutionsLife sciencesWall streetTitanium technologiesAdvanced performance materialsGlycolic acidIron path capitalPuretech scientific

The Chemours Company Agrees to Sell Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific Inc for $137 Million

The Chemours Company , a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials has entered into a. | June 10, 2023

United statesDenise dignamRob reistetterScott mrazMark newmanPuretech scientific incChemours companyGrace matthews incChemours chemical solutionsSpecialized solutionsLife sciencesTitanium technologiesAdvanced performance materialsGlycolic acidIron path capitalPuretech scientific

Global Clinical Chemistry Analyzer Market Size To Worth

The Global Clinical Chemistry Analyzer Market Size was valued at USD 15.01 Billion in 2021 and the worldwide clinical chemistry analyzer market size is.

Saudi arabiaSouth koreaNew yorkUnited statesSouth africaAsia pacificHoriba ltdTest basic metabolic panelBeckman coulterSurgical centersInquire before buying this researchThyroid function panelMindray medical international ltdAcademic research centersRandox laboratories ltdMetabolic panel

Infinium Pharmachem Ltd reports Net Profit of Rs 9 49 crore in FY23, growth of 55 4 per cent Y-o-Y

Gandhinagar, May 17 engaged in the manufacturing of Pharma Intermediates and APIs, Iodine derivatives has reported net profit of Rs. 9.49 crore for FY23, with Y-o-Y growth of 55.4% as compared to the net profit of Rs. 6.10 crore in FY22. Revenue from Operations grew 15.24% to Rs. 114.22 crore in FY23 as against revenue of Rs. 99.12 crore reported in FY22. Profit Before Tax during FY23 grew 50% to Rs. 12.95 crore as against Profit before Tax of Rs. 8.63 crore in FY22. EPS for FY23 is Rs. 18.67 per share.

United kingdomSun pharmaSanjaykumar patelInfinium pharmchemAtmanirbhar bharatInfinium pharmachem ltdContract researchSyngene internationalJunior national championshipInfinium green energy privateInfinium green energyManufacturing servicesDr reddy labNet profitPharma intermediatesBefore tax